ResearcherJesse Brown VA Medical CenterNo recent work listed
Kazumi Ebine
Matched on OpenAlex author ID A5012417250. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: 3 papers
Papers 6
- Interaction of tRNA with MEK2 in pancreatic cancer cells. Co-author DOI 10.1038/srep28260↗
- Slug inhibits pancreatic cancer initiation by blocking Kras-induced acinar-ductal metaplasia. Co-author DOI 10.1038/srep29133↗
- Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer. Co-author DOI 10.1158/1541-7786.mcr-15-0285↗
- GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1. Co-author DOI 10.1038/srep09489↗
- BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen. Co-author DOI 10.1158/1535-7163.mct-13-0925↗
- Three-dimensional collagen I promotes gemcitabine resistance in vitro in pancreatic cancer cells through HMGA2-dependent histone acetyltransferase expression. Co-author DOI 10.1371/journal.pone.0064566↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hidayatullah G. Munshi · 6 shared papers, 2013–2016 · strength 0.33
- Paper Interaction of tRNA with MEK2 in pancreatic cancer cells. DOI 10.1038/srep28260↗
- Paper Slug inhibits pancreatic cancer initiation by blocking Kras-induced acinar-ductal metaplasia. DOI 10.1038/srep29133↗
- Paper Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer. DOI 10.1158/1541-7786.mcr-15-0285↗
- Krishan Kumar · 5 shared papers, 2013–2016 · strength 0.26
- Paper Slug inhibits pancreatic cancer initiation by blocking Kras-induced acinar-ductal metaplasia. DOI 10.1038/srep29133↗
- Paper Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer. DOI 10.1158/1541-7786.mcr-15-0285↗
- Paper GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1. DOI 10.1038/srep09489↗
- David J. Bentrem · 3 shared papers, 2014–2016 · strength 0.15
- Paper Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer. DOI 10.1158/1541-7786.mcr-15-0285↗
- Paper GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1. DOI 10.1038/srep09489↗
- Paper BET bromodomain inhibitors block growth of pancreatic cancer cells in three-dimensional collagen. DOI 10.1158/1535-7163.mct-13-0925↗
- Lawrence M. Knab · 2 shared papers, 2014–2015 · strength 0.09
- Vaibhav Sahai · 2 shared papers, 2013–2014 · strength 0.09
- Brian T. DeCant · 1 shared paper, 2016 · strength 0.07
- Xiaoyun Wang · 1 shared paper, 2016 · strength 0.07
- Paul J. Grippo · 1 shared paper, 2016 · strength 0.07
- Leonidas C. Platanias · 1 shared paper, 2016 · strength 0.06
- Surabhi Y. Dangi-Garimella · 1 shared paper, 2013 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.